Hanne is project manager leading the development of innovative production pipelines for CAR T cell therapies.

With a deep passion for unraveling the complexities of fundamental biology, Hanne brings both scientific insight and hands-on expertise to our mission. At CellGENTherapies she will use her profound knowledge on cancer biology and immunology towards advancing next-generation ATMPs.

She holds a PhD in Biochemistry from Ghent University (UGent), where she explored the impact of epithelial-mesenchymal transition (EMT) on cell death and immunogenicity in colorectal cancer.